Placebo-controlled multicentre randomised trial of interferon ß-1b in treatment of secondary progressive multiple sclerosis.

  • L Kappos
  • , Study Group on Interferon β-1b in Secondary Progressive MS European
  • , CO Hanemann

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1491-1497
Number of pages6
JournalThe Lancet
Volume352
Issue number9139
DOIs
Publication statusPublished - 7 Nov 1998

Cite this